Cambridge Nutritional Sciences Announces Holding Change
The healthcare company has announced a change in shareholding, with IG Markets Limited increasing its stake to just under 3% of the voting rights.
The healthcare company has announced a change in shareholding, with IG Markets Limited increasing its stake to just under 3% of the voting rights.
The medical diagnostics company reports strong profit growth and an attractive valuation, despite some short-term challenges.
The healthcare company has resolved a historical health and safety issue at one of its subsidiaries, with a minor fine imposed.
The medical diagnostics company has granted share options to its Chief Executive Officer.
The healthcare company has appointed a new Chief Executive Officer to lead the business forward.
The healthcare company has announced changes to its major shareholdings.
The healthcare company provides an update on a legal matter regarding a former subsidiary that was sold in 2018.
The healthcare company has disclosed a change in director shareholdings.
The medical diagnostics company's Non-Executive Chair has purchased 100,000 shares, increasing their total holding to 0.08% of the issued share capital.
The medical diagnostics company announced a director has purchased a small number of shares, but provided limited additional context.